BC Extra | Dec 21, 2019
Management Tracks: Ionis promotes co-founder to CSO; Syros adds Celgene vet Alles to board; plus Encoded, Cygnal, Harvard Medical School, Immunitas and more
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) said co-founder C. Frank Bennett will become CSO, with Eric Swayze succeeding him as SVP of research. Bennett will remain the antisense oligonucleotide company’s franchise leader for neurology drug discovery. Swayze...